All Stories

  1. Damage by being put on a mechanical ventilator gets worse with aging.
  2. Collagen Tubular Airway‐on‐Chip for Extended Epithelial Culture and Investigation of Ventilation Dynamics
  3. Pulmonary Surfactant: A Mighty Thin Film
  4. Bronchopneumonia with interstitial pneumonia in beef feedlot cattle: Characterization and laboratory investigation
  5. The negative effect of vaping on the material that stabilizes your lung, surfactant.
  6. Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome
  7. The effect of maternal protein restriction during perinatal life on the inflammatory response in pediatric rats
  8. National Preclinical Sepsis Platform: developing a framework for accelerating innovation in Canadian sepsis research
  9. Can a drug used to help premature babies breathe also be of benefit in patients with COVID-19?
  10. The impact of maternal protein restriction during perinatal life on the response to a septic insult in adult rats
  11. Exogenous Surfactant as a Pulmonary Delivery Vehicle for Budesonide In Vivo
  12. Novel Functions and Signaling Specificity for the GraS Sensor Kinase of Staphylococcus aureus in Response to Acidic pH
  13. Optimizing a novel therapy for bacterial lung infections.
  14. Therapy to reduce the damaging effects of mechanical ventilation
  15. The effects of aging and exercise on lung mechanics, surfactant and alveolar macrophages
  16. Delivery of lung therapeutics using surfactant: a review
  17. Low protein diet during pregnancy will have effect on the lungs of the offspring.
  18. Autocrine GABA signaling distinctively regulates phenotypic activation of mouse pulmonary macrophages
  19. Designing an artificial therapeutic for lung diseases
  20. Dysfunction of pulmonary surfactant mediated by phospholipid oxidation is cholesterol-dependent
  21. Alveolar injury and regeneration following deletion of ABCA3
  22. A new potential therapy for bacterial lung infections
  23. Killing of Pseudomonas aeruginosa by Chicken Cathelicidin-2 Is Immunogenically Silent, Preventing Lung Inflammation In Vivo
  24. Impact of ventilation-induced lung injury on the structure and function of lamellar bodies
  25. Studying the effect of exercise on acute inflammation in old mice
  26. A respiratory-gated micro-CT comparison of respiratory patterns in free-breathing and mechanically ventilated rats
  27. Lung remodeling associated with recovery from acute lung injury
  28. The effect of diet-induced serum hypercholesterolemia on the surfactant system and the development of lung injury
  29. Lack of matrix metalloproteinase 3 in mouse models of lung injury ameliorates the pulmonary inflammatory response in female but not in male mice
  30. The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury
  31. Decreased neuroinflammation correlates to higher vagus nerve activity fluctuations in near-term ovine fetuses: a case for the afferent cholinergic anti-inflammatory pathway?
  32. Antimicrobial and Biophysical Properties of Surfactant Supplemented with an Antimicrobial Peptide for Treatment of Bacterial Pneumonia
  33. Cholesterol-mediated surfactant dysfunction is mitigated by surfactant protein A
  34. Apolipoprotein E-Deficient Mice Are Susceptible to the Development of Acute Lung Injury
  35. The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury
  36. Adaptations to hibernation in lung surfactant composition of 13-lined ground squirrels influence surfactant lipid phase segregation properties
  37. Specific cleavage of the lung surfactant protein A by human cathepsin S may impair its antibacterial properties
  38. Human Alveolar Epithelial Cells Attenuate Pulmonary Microvascular Endothelial Cell Permeability under Septic Conditions
  39. Lung-Derived Mediators Induce Cytokine Production in Downstream Organs via anNF-κB-Dependent Mechanism
  40. Adaptation to low body temperature influences pulmonary surfactant composition thereby increasing fluidity while maintaining appropriately ordered membrane structure and surface activity
  41. The Impact of Intermittent Umbilical Cord Occlusions on the Inflammatory Response in Pre-Term Fetal Sheep
  42. A modified squeeze-out mechanism for generating high surface pressures with pulmonary surfactant
  43. Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids
  44. Atomic force microscopy analysis of rat pulmonary surfactant films
  45. The biological effects of lung-derived mediators on the liver
  46. A ToF-SIMS study of the lateral organization of lipids and proteins in pulmonary surfactant systems
  47. The Effect of Tidal Volume on Systemic Inflammation in Acid-Induced Lung Injury
  48. Recent advances in alveolar biology: Some new looks at the alveolar interface
  49. Surfactant protein-A reduces translocation of mediators from the lung into the circulation
  50. IL-6 and TNFα across the umbilical circulation in term pregnancies: Relationship with labour events
  51. High-frequency oscillation and surfactant treatment in an acid aspiration model
  52. Role of cholesterol in the biophysical dysfunction of surfactant in ventilator-induced lung injury
  53. Systemic and cerebral inflammatory response to umbilical cord occlusions with worsening acidosis in the ovine fetus
  54. Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes
  55. Quantifying lung morphology with respiratory-gated micro-CT in a murine model of emphysema
  56. ELEVATED ENDOGENOUS SURFACTANT REDUCES INFLAMMATION IN AN ACUTE LUNG INJURY MODEL
  57. THE EFFECTS OF HYPEROXIA EXPOSURE ON LUNG FUNCTION AND PULMONARY SURFACTANT IN A RAT MODEL OF ACUTE LUNG INJURY
  58. Current perspectives in pulmonary surfactant — Inhibition, enhancement and evaluation
  59. Atomic Force Microscopy Studies of Functional and Dysfunctional Pulmonary Surfactant Films, II: Albumin-Inhibited Pulmonary Surfactant Films and the Effect of SP-A
  60. The effects of long-term conventional mechanical ventilation on the lungs of adult rats*
  61. Alterations to surfactant precede physiological deterioration during high tidal volume ventilation
  62. Atomic Force Microscopy Studies of Functional and Dysfunctional Pulmonary Surfactant Films. I. Micro- and Nanostructures of Functional Pulmonary Surfactant Films and the Effect of SP-A
  63. Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
  64. Protective effects of elevated endogenous surfactant pools to injurious mechanical ventilation
  65. The anatomy, physics, and physiology of gas exchange surfaces: is there a universal function for pulmonary surfactant in animal respiratory structures?
  66. Contribution of alveolar macrophages to the response of the TIMP-3 null lung during a septic insult
  67. Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats
  68. Effect of Cholesterol on the Biophysical and Physiological Properties of a Clinical Pulmonary Surfactant
  69. In vivo characterization of lung morphology and function in anesthetized free-breathing mice using micro-computed tomography
  70. LUNG MECHANICS IN THE TIMP3 NULL MOUSE AND ITS RESPONSE TO MECHANICAL VENTILATION
  71. Physiological effects of oxidized exogenous surfactant in vivo: effects of high tidal volume and surfactant protein A
  72. The Future of Surfactant Therapy during ALI/ARDS
  73. Pre-emptive and continuous inhaled NO counteracts the cardiopulmonary consequences of extracorporeal circulation in a pig model
  74. INTERLEUKIN-6 HAS NO EFFECT ON SURFACTANT OR LUNG FUNCTION IN DIFFERENT LUNG INSULTS
  75. Mechanisms responsible for surfactant changes in sepsis-induced lung injury
  76. Differential response of TIMP-3 null mice to the lung insults of sepsis, mechanical ventilation, and hyperoxia
  77. Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions
  78. PROTEIN INHIBITION OF SURFACTANT DURING MECHANICAL VENTILATION OF ISOLATED RAT LUNGS
  79. Host response to intratracheally instilled bacteria in ventilated and nonventilated rats
  80. Ventilation and oxygen: Just what the doctor ordered. . .Unfortunately*
  81. Hyperoxia exposure impairs surfactant function and metabolism
  82. Physiological and inflammatory response to instillation of an oxidized surfactant in a rat model of surfactant deficiency
  83. Negative impact of tissue inhibitor of metalloproteinase-3 null mutation on lung structure and function in response to sepsis
  84. High-frequency oscillation and exogenous surfactant administration in lung-injured adult sheep
  85. Early surfactant administration protects against lung dysfunction in a mouse model of ARDS
  86. High oxygen concentrations predispose mouse lungsto the deleterious effects of high stretch ventilation
  87. The Role of Exogenous Surfactant in the Treatment of Acute Lung Injury
  88. Sepsis and hyperoxia effects on the pulmonary surfactant system in wild-type and iNOS knockout mice
  89. Mechanical ventilation of isolated rat lungs changes the structure and biophysical properties of surfactant
  90. Evaluation of alveolar surfactant aggregatesin vitroandin vivo
  91. Effects of alveolar surfactant aggregates on T-lymphocyte proliferation
  92. Effects of mechanical ventilation of isolated mouse lungs on surfactant and inflammatory cytokines
  93. SURFACTANT TREATMENT FOR VENTILATION-INDUCED LUNG INJURY IN RATS: EFFECTS ON LUNG COMPLIANCE AND CYTOKINES
  94. Dissociation of surfactant protein B from canine surfactant large aggregates during formation of small surfactant aggregates by in vitro surface area cycling
  95. AN EXAMINATION OF THE DIFFERENT VARIABLES AFFECTING SURFACTANT AGGREGATE CONVERSION IN VITRO
  96. The role of lipids in pulmonary surfactant
  97. Mitigation of injury in canine lung grafts by exogenous surfactant therapy
  98. THE EFFECT OF LUNG PRESERVATION ON ALVEOLAR SURFACTANT
  99. Surfactant: Current and Potential Therapeutic Application in Infants and Adults
  100. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.
  101. Factors Influencing Efficacy of Exogenous Surfactant in Acute Lung Injury
  102. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis
  103. Surfactant analysis and replacement therapy: A future tool of the lung transplant surgeon?
  104. Rat liver and lung mitochondria do not incorporate radioactivity from glycerol-3-phosphate or CDP-choline into glycero-3-phosphocholine
  105. Examination of the potential role of the glycerophosphorylcholine (GPC) pathway in the biosynthesis of phosphatidylcholine by liver and lung